Cel Sci Corp
CVM- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000725363
In the last 90 days, Cel Sci Corp insiders filed 1 open-market purchase and 0 sales; 40 institutions reported holding it in 13F filings for Q2 2026, worth $2.08M in total; no superinvestor holds it.
Key figures
- Insider buysLast 90 days, $138.0K in total
- 1
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, +1 vs. previous quarter
- 40
- 13F valueReported value at the end of Q2 2026
- $2.08M
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding CVM, Q2 2026
No superinvestor reported holding CVM at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Cel Sci Corp insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 26, 2026 (view filing)8:32 AM ET | Aug 25 | 1 day | Kersten Geert RChief Executive Officer | PPurchase | +100.0K | $1.38 | +$138.0K | +46.3%316.1K after | |
| May 18, 2026 (view filing) | May 14 | 4 days | Kersten Geert RChief Executive Officer | PPurchase | +300.0K | $1.20 | +$360.0K | +2,598.1%311.5K after | |
| May 14, 2026 (view filing) | May 13 | 1 day | Kersten Geert RChief Executive Officer | PPurchase | +100.0K | $1.19 | +$119.0K | +81.6%222.5K after | |
| Jan 26, 2026 (view filing) | Jan 22 | 4 days | Kersten Geert RChief Executive Officer | PPurchase | +38.0K | $5.26 | +$200.0K | +45.9%120.8K after | |
| Dec 5, 2025 (view filing) | Dec 4 | 1 day | Kersten Geert RChief Executive Officer | PPurchase | +8.39K | $5.96 | +$50.0K | +11.4%81.8K after | |
| Jul 29, 2025 (view filing) | Jul 25 | 4 days | Watson Robert EugeneDirector | PPurchase | +2.92K | $6.85 | +$20.0K | +358.6%3.73K after | |
| Jul 28, 2025 (view filing) | Jul 25 | 3 days | Kersten Geert RChief Executive Officer | PPurchase | +29.2K | $6.85 | +$200.0K | +66.9%72.8K after | |
| May 10, 2024 (view filing) | May 8 | 2 days | Watson Robert EugeneDirector | PPurchase | +20.0K | $1.39 | +$27.8K | +451.4%24.4K after | |
| May 9, 2024 (view filing) | May 8 | 1 day | Prichep Patricia BSenior Vice President | PPurchase | +8.00K | $1.39 | +$11.1K | +3.6%232.3K after | |
| May 9, 2024 (view filing) | May 8 | 1 day | Kersten Geert RChief Executive Officer | PPurchase | +30.0K | $1.39 | +$41.7K | +2.6%1.20M after |
Top 10 13F holders, Q2 2026
The largest institutional positions in Cel Sci Corp at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Renaissance Technologies LLC | 572,460 | $595.4K | 0.00% | +536,570+1,495.0% | Added |
| Vanguard Capital Management LLC | 543,079 | $564.8K | 0.00% | +299,434+122.9% | Added |
| Citadel Advisors LLC | 198,500 | $206.4K | 0.00% | +198,500 | New |
| MAI Capital Management | 108,280 | $112.6K | 0.00% | +17,000+18.6% | Added |
| Geode Capital Management, LLC | 88,200 | $91.8K | 0.00% | +2,889+3.4% | Added |
| Commonwealth Equity Services, LLC | 51,434 | $53.5K | 0.00% | +33,812+191.9% | Added |
| HRT Financial LP | 51,155 | $53.0K | 0.00% | +51,155 | New |
| Vanguard Fiduciary Trust Co | 49,036 | $51.0K | 0.00% | 00.0% | Unchanged |
| BlackRock, Inc. | 43,261 | $45.0K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 40,916 | $42.6K | 0.00% | −81−0.2% | Reduced |